Articles

Larimar Therapeutics

Larimar Therapeutics Advances Nomlabofusp Clinical Program with First Patient Dosed in Open Label Extension Study

BALA CYNWYD, PA — Clinical-stage biotechnology company Larimar Therapeutics, Inc. (Nasdaq: LRMR) has announced the dosing of the first patient in an open label extension (OLE) study for its novel …

Larimar Therapeutics Advances Nomlabofusp Clinical Program with First Patient Dosed in Open Label Extension Study Read More

Centrak

CenTrak Unveils Industry’s First Scalable Bluetooth Low Energy Multi-Mode Platform for Healthcare

NEWTOWN, PA — CenTrak, a leader in the healthcare technology sector, has announced its latest breakthrough: the industry’s first scalable Bluetooth Low Energy (BLE) Multi-Mode Platform. This pioneering Real-Time Location …

CenTrak Unveils Industry’s First Scalable Bluetooth Low Energy Multi-Mode Platform for Healthcare Read More

Aprea Therapeutics

FDA Greenlights Aprea Therapeutics’ Investigational New Drug Application for Novel Cancer Treatment

DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE), a clinical-stage biopharmaceutical company, has announced that its Investigational New Drug (IND) application for APR-1051 has been cleared by the U.S. Food …

FDA Greenlights Aprea Therapeutics’ Investigational New Drug Application for Novel Cancer Treatment Read More


Chrissy Houlahan

Rep. Houlahan Secures Over $11.7 Million in Community Project Funding for Southern Berks and Chester Counties

WASHINGTON, D.C. —  Representative Chrissy Houlahan (D-PA) has successfully secured the funding of 14 Community Project Funding priorities, amassing a whopping $11,726,065 through the House Appropriations Committee. This remarkable initiative …

Rep. Houlahan Secures Over $11.7 Million in Community Project Funding for Southern Berks and Chester Counties Read More